• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    (NY: ALUR )

    0.7148 -0.0152 (-2.08%)
    Streaming Delayed Price Updated: 2:53 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about ALUR

    < Previous 1 2 Next >
    Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss
    From Allurion Technologies, Inc.
    Via Business Wire
    October's 4 Best Penny Stocks: High-Risk, High-Reward Picks
    Penny stocks are a risky but potentially rewarding opportunity for investors willing to take on their uncertainty; these stocks may stand out from the pack. 
    Via MarketBeat
    Topics Bankruptcy
    Exposures Financial Legal
    Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Receives Continued Listing Standards Notice from NYSE
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Receives Continued Listing Standards Notice from NYSE
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Launch of Offering of Common Stock and Warrants
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion to Participate in Two Upcoming Investor Conferences in June 2024
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Announces Preliminary First Quarter 2024 Results
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Expands Virtual Care Suite to the United States
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
    From Allurion Technologies, Inc.
    Via Business Wire
    Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
    From Allurion Technologies, Inc.
    Via Business Wire
    Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
    From Allurion Technologies, Inc.
    Via Business Wire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.